why choose us

First received: May 30, 2023

Clinical Trial: A Study of BA1202 in Patients With Advanced Solid Tumors

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Advanced Solid Tumor

Study Type: INTERVENTIONAL


Official Title: A Multicenter, Open-label, Single-arm, Dose Escalation and Expansion Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of BA1202 in Patients With Advanced S

Brief Summary: This is a multicenter, open-label, single-arm phase I study in patients with advanced solid tumors which consists of a dose escalation part (Part A) and a dose extension part (Part B).Part A aims to evaluate the safety and tolerability of BA1202, and determine the MTD.Part B will also evaluate the preliminary efficacy of BA1202.

Read more